- EEA Grants
- Granturi SEE
- UMF Cluj
- UBB Cluj


All the partners have been involved in previous national and international projects, frequently as work package leaders and often as coordinators. The success of achieving the objective of the project and decision-making procedures of the project will be based upon the experience of partners gained in carrying out large multi-disciplinary national and international projects. The multi-disciplinary nature of the partners involved is necessitated by the project objectives and will provide for excellent exchange of skills, expertise and knowledge. All the partners have the infrastructure and expertise required by the project objectives. Interactions between human and animal scientists, between molecular, cellular, and medical doctors will also provide for significant exchange of skills, expertise and knowledge than will significantly enrich the European science base.

The Iuliu Hatieganu University of Medicine and Pharmacy will coordinate the project and will play the key role in management, also will be responsible for a part of the fundamental research and genetic and proteomic study, along with the other involved institutions. The Ion Chiricuta Institute of Oncology will act in a tight collaboration with the Babes Bolyai University and the University of Bergen. They will assess the clinical impact of this research, regarding the applications of nanotechnology in life quality and treatment response. The Ion Chiricuta Institute of Oncology will also evaluate the clinical follow-up for the two lots of patients included in study, as well as provide the biological materials for genetic and proteomic study done by the other partners. In addition the universities involved will have an analytical role, including carry out some biochemical test for quantify the response to therapy and for integration of the experimental data obtained, as well as to organize seminars and workshops in order to teach the latest protocols to young researchers from Romania and Norway.

A particularly interest is to integrate all the experimental data obtained from fundamental research and translational research done in the university setting, leading to develop a novel prototype cancer therapy by combining classical standard-of-care with novel approaches in biomedical engineering in order to increase the response to treatment and life quality.

Our research project provides a collaborative research environment and promotes interactions between investigators in the basic science and clinical departments. It proves that the basic research and translational research are intimately connected. All the partners will have active participate on achieving the project objective and will participate for the dissemination and exploitation of the experimental results.

If you are interested in a future collaboration with our team contact us . . .